Arbutus Biopharma Corp (NASDAQ:ABUS) gets downgraded to Neutral by Chardan Capital

Analyst Ratings For Arbutus Biopharma Corp (NASDAQ:ABUS)

Story continues below

Today, Arbutus Biopharma Corp (NASDAQ:ABUS) stock was downgraded by Chardan Capital from Buy to Neutral.

There are 4 Hold Ratings, 1 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on Arbutus Biopharma Corp (NASDAQ:ABUS) is Hold with a consensus target price of $6.33 per share, a potential 342.89% upside.

Some recent analyst ratings include

  • 10/4/2019-Arbutus Biopharma Corp (NASDAQ:ABUS) gets downgraded to Neutral by Chardan Capital
  • 3/11/2019-Arbutus Biopharma Corp (NASDAQ:ABUS) had its Hold rating reiterated by Echelon Wealth Partners
  • 10/16/2018-Arbutus Biopharma Corp (NASDAQ:ABUS) gets upgraded to Buy by B. Riley with a price target of $9.00
  • 10/15/2018-Arbutus Biopharma Corp (NASDAQ:ABUS) gets upgraded to Neutral by Wedbush with a price target of $5.00
  • 11/7/2017-Arbutus Biopharma Corp (NASDAQ:ABUS) had its Market Perform rating reiterated by Leerink Swann with a $5.00 price target
  • On 8/13/2018 Michael J Sofia, Insider, sold 4,250 with an average share price of $9.51 per share and the total transaction amounting to $40,417.50.
  • On 7/11/2018 Michael J Sofia, Insider, sold 10,000 with an average share price of $10.00 per share and the total transaction amounting to $100,000.00.
  • On 7/9/2018 Michael J Sofia, Insider, sold 10,000 with an average share price of $8.91 per share and the total transaction amounting to $89,100.00.
  • On 7/5/2018 Michael J Sofia, Insider, sold 20,000 with an average share price of $8.20 per share and the total transaction amounting to $164,000.00.
  • On 7/3/2018 Michael J Sofia, Insider, sold 10,000 with an average share price of $8.00 per share and the total transaction amounting to $80,000.00.
  • On 10/3/2017 Michael J Sofia, Insider, sold 10,000 with an average share price of $8.00 per share and the total transaction amounting to $80,000.00.
  • On 8/15/2017 Michael J Sofia, Insider, sold 30,000 with an average share price of $3.70 per share and the total transaction amounting to $111,000.00.

Recent Trading Activity for Arbutus Biopharma Corp (NASDAQ:ABUS)
Shares of Arbutus Biopharma Corp closed the previous trading session at 1.43 up +0.050 3.62% with 1.43 shares trading hands.

An ad to help with our costs